Results 201 to 210 of about 19,951 (230)

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Extracorporeal membrane oxygenation in cardiovascular medication poisoning. A German-wide retrospective study. [PDF]

Sci Rep
Friedrichson B, Jasny T, Old O, Piekarski F, Ippolito A, Raimann FJ, Zacharowski K, Kloka JA.   +7 more
europepmc   +1 more source

Impact of a 12‐week High‐Intensity Interval Training With Spirulina Supplementation on Insulin Resistance‐Mediated by Apo‐A, ‐B, and ‐J in Men With Obesity

European Journal of Sport Science, Volume 25, Issue 4, April 2025.
ABSTRACT Obesity is a significant public health issue associated with an elevated risk of chronic diseases. Discovering appropriate exercise interventions combined with beneficial herbal supplements has always been investigated. Hence, our study aimed to assess the impact of 12 weeks of high‐intensity interval training (HIIT) and spirulina ...
Seyed Morteza Tayebi, Parisa Bagherian, Minoo Bassami, Aref Basereh, Somayeh Ahmadabadi   +4 more
wiley   +1 more source

Alpha-adrenergic antagonists and iris dynamics: Challenges and solutions in cataract surgery. [PDF]

BMC Ophthalmol
Kaushik J, Sharma R, Goyal S, Dangi M, Jha RK, Singh A.   +5 more
europepmc   +1 more source

Comparative Analysis of Primary Sarcopenia and End‐Stage Renal Disease–Related Muscle Wasting Using Multi‐Omics Approaches

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 2, April 2025.
ABSTRACT Background Age‐related primary sarcopenia and end‐stage renal disease (ESRD)–related muscle wasting are discrete entities; however, both manifest as a decline in skeletal muscle mass and strength. The etiological pathways differ, with aging factors implicated in sarcopenia and a combination of uremic factors, including haemodialysis ...
Daiki Setoyama, Dohyun Han, Jingwen Tian, Ho Yeop Lee, Hyun Suk Shin, Ha Thi Nga, Thi Linh Nguyen, Ji Sun Moon, Hyo Ju Jang, Evonne Kim, Seong‐Kyu Choe, Sang Hyeon Ju, Dae Eun Choi, Obin Kwon, Hyon‐Seung Yi   +14 more
wiley   +1 more source

Effect of the Administration of Cautionary Drugs on the Risk of Worsening Myasthenia Gravis: A Retrospective Matched Case-Control Study. [PDF]

Yonsei Med J
Han HJ, Kim SW, Lee M, Kim HR, Roh YH, Shin HY.   +5 more
europepmc   +1 more source

Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer's disease. [PDF]

J Neuroinflammation
Evans AK, Park HH, Woods CE, Lam RK, Rijsketic DR, Xu C, Chu EK, Ciari P, Blumenfeld S, Vidano LM, Saw NL, Heifets BD, Shamloo M.   +12 more
europepmc   +1 more source

Application of UHPLC-QqQ-MS/MS Method for Quantification of Beta-Adrenergic Blocking Agents (β-Blockers) in Human Postmortem Specimens. [PDF]

Molecules
Szpot P, Tusiewicz K, Wachełko O, Zawadzki M.   +3 more
europepmc   +1 more source

Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis. [PDF]

Cochrane Database Syst Rev
Oba Y, Pathak M, Maduke T, Fakhouri EW, Dias S.   +4 more
europepmc   +1 more source